Lilly's Kisunla (Donanemab) Receives Marketing Authorization in Australia for the Treatment of Early Symptomatic Alzheimer's Disease

An intact memory ensures a higher quality of life in old age. Neuroscientist Matthias Pawlowski explains what we can do to prevent dementia.

Researchers found a molecule that reverses brain aging

New research shows that we may be able to reverse brain aging with a single molecule, but more research is needed to prove it.

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

Potential new drug that protects blood-brain barrier shows promise against Alzheimer's

Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's disease (AD) and other conditions that destroy cells in the brain and nervous system.

‘Hope’: Huge leap in dementia treatment

A breakthrough drug expected to give back years to hundreds of thousands of Australians suffering through a debilitating disease has been approved.

Prescription drug to slow Alzheimer’s disease approved in Australia

A groundbreaking treatment to slow the progression of Alzheimer's Disease has been cleared for prescription in Australia. The Therapeutic Goods Administration has approved the medication for some people with early disease symptoms. It's the first new treatment of its kind in 25 years.